Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino Pathiparampil
Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.
Scientific American2h
What’s in ZYN, the FDA-Authorized Nicotine Pouch? Is It Harmful?
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
Indiatimes17h
Mankind Pharma Share Price
Mankind Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Royalty Income for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...
The Australian Financial Review14h
Neuren Pharmaceuticals Limited
Biopharmaceutical company developing drugs for neurological disorders.